A Phase IIa, Randomized, Placebo-controlled, Double-blind, Cross-over Study to Evaluate Safety and Efficacy of Subcutaneous Administration of Anakinra in Patients With Cystic Fibrosis

Condition:   Cystic Fibrosis, 10011762 Intervention:   Drug: Anakinra Sponsor:   Heidelberg University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials